Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Harry Owusu-Boateng"'
Autor:
Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans, Amos Kotey, Pascale Vandoolaeghe, Mark Cullinane, Magali Traskine, Florence Ouedraogo, David Sambian, Marc Lievens, Marc Christian Tahita, Erik Jongert, Palpouguini Lompo, Ali Idriss, Dorota Borys, Sayouba Ouedraogo, Frank Prempeh, Lode Schuerman, Hermann Sorgho, Tsiri Agbenyega
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1464-1470 (2020)
RTS,S/AS01E malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impact of RTS,S/AS01E when implemented in the Expanded Program of Immunization, infants 8–12 weeks old
Externí odkaz:
https://doaj.org/article/fc88a75214814b4181d957a8ec82fef3
Autor:
Innocent Valéa, Samuel Adjei, Effua Usuf, Ousmane Traore, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Amanda Leach, Athanase Mwinessobaonfou Some, Patrick Buabeng, Johan Vekemans, Louis Arnaud Nana, Amos Kotey, Pascale Vandoolaeghe, Florence Ouedraogo, David Sambian, Marc Lievens, Marc Christian Tahita, Theresa Rettig, Erik Jongert, Palpouguini Lompo, Ali Idriss, Dorota Borys, Sayouba Ouedraogo, Frank Prempeh, Md Ahsan Habib, Lode Schuerman, Hermann Sorgho, Tsiri Agbenyega
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1489-1500 (2018)
The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-ty
Externí odkaz:
https://doaj.org/article/1161027a5eef47e6be6997a269ed1613
Autor:
Chris Drakeley, Salim Abdulla, Selidji Todagbe Agnandji, José Francisco Fernandes, Peter Kremsner, Bertrand Lell, Ludovic Mewono, Bache Emmanuel Bache, Michael Gabriel Mihayo, Omar Juma, Marcel Tanner, Marc Christian Tahita, Halidou Tinto, Salou Diallo, Palpouguini Lompo, Umberto D’Alessandro, Bernhards Ogutu, Lucas Otieno, Solomon Otieno, Walter Otieno, Janet Oyieko, Kwaku Poku Asante, Dominic Bon-Ereme Dery, George Adjei, Elisha Adeniji, Dorcas Atibilla, Seth Owusu-Agyei, Brian Greenwood, Samwel Gesase, John Lusingu, Coline Mahende, Robert Mongi, Method Segeja, Samuel Adjei, Tsiri Agbenyega, Alex Agyekum, Daniel Ansong, John Tanko Bawa, Harry Owusu Boateng, Léonard Dandalo, Veronica Escamilla, Irving Hoffman, Peter Maenje, Francis Martinson, Terrell Carter, Didier Leboulleux, David C. Kaslow, Effua Usuf, Jean-Yves Pirçon, Edith Roset Bahmanyar
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-15 (2017)
Abstract Background Plasmodium falciparum prevalence (PfPR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS,S/AS01 candidate malaria vaccine Phase III trial and estimated PfPR
Externí odkaz:
https://doaj.org/article/6e058e429cf64226b67c39b4bafbf55f
Autor:
Tsiri Agbenyega, Seyram Kaali, Elisha Adeniji, Daniel Ansong, Japhet Adomako Anim, Samuel Adjei, Clara Agutu, Pascale Vandoolaeghe, Harry Owusu-Boateng, Emilia Gvozdenovic, Patrick Boakye Yiadom Buabeng, Frank Prempeh, David Sambian, Kwaku Poku Asante, Opokua Ofori-Anyinam, Samuel Benard Ekow Harrison, Theresa Rettig, Albert Agordo Dornudo, Yaw Ntiamoah, David Dosoo, Elvis Ato Wilson, Lode Schuerman, Marc Lievens, Prince Agyapong Darko, Seth Owusu-Agyei, Lydia Nana Badu, Owusu Boahen
Publikováno v:
Vaccine
Background To optimize vaccine implementation visits for young children, it could be efficient to administer the first RTS,S/AS01 malaria vaccine dose during the Expanded Programme on Immunization (EPI) visit at 6 months of age together with Vitamin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19735feece32caa57915eff9ba2267fa
https://doi.org/10.1016/j.vaccine.2020.03.014
https://doi.org/10.1016/j.vaccine.2020.03.014
Autor:
Frank Prempeh, Johan Vekemans, Effua Usuf, Samuel Adjei, Dorota Borys, Mark Cullinane, Ali Idriss, Harry Owusu Boateng, Pascale Vandoolaeghe, Innocent Valea, Athanase M Some, Ousmane Traore, Amos Kotey, Marc Christian Tahita, Erik Jongert, Hermann Sorgho, Sayouba Ouedraogo, Marc Lievens, Lode Schuerman, Magali Traskine, Tsiri Agbenyega, David Sambian, Daniel Ansong, Halidou Tinto, Patrick Buabeng, Palpouguini Lompo, Florence Ouedraogo
Publikováno v:
Human Vaccines & Immunotherapeutics. 16:1464-1470
RTS,S/AS01E malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impact of RTS,S/AS01E when implemented in the Expan...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6907f153881dc187ca11199cf172ab0d
https://doi.org/10.1080/21645515.2019.1695457
https://doi.org/10.1080/21645515.2019.1695457
Autor:
Theresa Rettig, Palpouguini Lompo, Hermann Sorgho, Innocent Valea, Ousmane Traore, Frank Prempeh, Florence Ouedraogo, Patrick Boakye Yiadom Buabeng, Ahsan Habib, Samuel Adjei, Daniel Ansong, Halidou Tinto, David Sambian, Pascale Vandoolaeghe, Erik Jongert, Effua Usuf, Marc Lievens, Sayouba Ouedraogo, Amanda J. Leach, Amos Kotey, Tsiri Agbenyega, Johan Vekemans, Louis Arnaud Nana, Dorota Borys, Ali Idriss, Lode Schuerman, Marc Christian Tahita, Athanase M Some, Harry Owusu Boateng
Publikováno v:
Human Vaccines & Immunotherapeutics
The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76879fd7dd2a33fdc7bf7977a50319f2
https://doi.org/10.1080/21645515.2018.1442996
https://doi.org/10.1080/21645515.2018.1442996
Autor:
Lucas Otieno, Bernhards Ogutu, Palpouguini Lompo, John Bawa, Selidji T Agnandji, Method D. Segeja, George Adjei, Effua Usuf, Francis Martinson, Harry Owusu Boateng, Bache Emmanuel Bache, Walter Otieno, Kwaku Poku Asante, Didier Leboulleux, Daniel Ansong, Salou Diallo, Ludovic Mewono, Tsiri Agbenyega, Halidou Tinto, Samuel Adjei, Omar Juma, Salim Abdulla, Peter Maenje, Brian Greenwood, Janet Oyieko, Jean-Yves Pirçon, Bertrand Lell, Robert Mongi, John Lusingu, Veronica Escamilla, Alex Agyekum, Dominic B Dery, David C. Kaslow, Elisha Adeniji, Terrell Carter, Seth Owusu-Agyei, Chris Drakeley, Solomon Otieno, Peter G. Kremsner, José Francisco Fernandes, Edith Roset Bahmanyar, Irving F. Hoffman, Coline Mahende, Marc Christian Tahita, Dorcas Atibilla, Umberto D'Alessandro, Leonard Dandalo, Marcel Tanner, Michael G. Mihayo, Samwel Gesase
Publikováno v:
Malaria Journal
Malaria Journal, Vol 16, Iss 1, Pp 1-15 (2017)
Malaria Journal, Vol 16, Iss 1, Pp 1-15 (2017)
Background Plasmodium falciparum prevalence (PfPR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS,S/AS01 candidate malaria vaccine Phase III trial and estimated PfPR over ≤
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8544600695c0ff49b0a5fa5c05299322
https://pubmed.ncbi.nlm.nih.gov/29078773
https://pubmed.ncbi.nlm.nih.gov/29078773
Autor:
Jahit Sacarlal, Agnes Akoth Onyango, Jackton Omoto, Portia Kamthunzi, Norbert Awino, Samuel Ayamba, Yolanda Guerra, Tisungane Mvalo, Diana Quelhas, Daniel Ansong, Didier Leboulleux, Béatrice Peggy Abossolo, Halidou Tinto, Dalitso Nyakuipa, Tsiri Agbenyega, Victorine Owira, Roma Chilengi, Kingsley Kayan, David Sambian, Terrell Carter, Ali Ali, Martha M. Lemnge, Cornelia Conzelmann, Seth Owusu-Agyei, Quique Bassat, Jean-Bosco Ouédraogo, William Kabore, José Francisco Fernandes, Chris Drakeley, Peter G. Kremsner, Afiya Radford, Saadou Issifou, Philip Bejon, Umberto D'Alessandro, Christian Loucq, Chris Odero, Francisca Machera, Pedro L. Alonso, Ali Mtoro, Theresa Rettig, John Lusingu, Albans Msika, Kwaku Poku Asante, Brian Greenwood, Alex Agyekum, George Adjei, Ruth Wasuna, Innocent Valea, Ali Hamad, Irving F. Hoffman, Rose Minja, Nelecy Chome, John Williamson, Charity Maingi, Salim Abdulla, Omar Juma, Amanda J. Leach, Stacey M. O. Gondi, W. Ripley Ballou, Mwanajaa Shomari, Johan Vekemans, Opokua Ofori-Anyinam, Hermann Sorgho, Samwel Gesase, Myriam Bruls, Allan Otieno, Barbara Gaelle Nfono Ondo Methogo, Kephas Otieno, David Dosoo, Benjamin Mordmüller, Walter Otieno, John J. Aponte, Yannick Doucka, Bertrand Lell, Didier Lapierre, Joe Cohen, Selidji T Agnandji, Coline Mahende, Alwisa Urassa, Lucas Otieno, Sofia Mandjate, David B. Jones, Samuel Adjei, Mary J. Hamel, Martina Oneko, Bernhards Ogutu, Hassan Kilavo, Marla Sillman, Isaac Asante, Ruth Owusu-Ofori, Preeti Vansadia, Laurence Slutsker, Sayouba Ouedraogo, John Bawa, Christine Kerubo, Omari Abdul, Pedro Aide, Justice Sylverken, Marcel Tanner, Barbara Savarese, David Schellenberg, Marc Christian Tahita, Norbert Peshu, Yara Sandrine, Owusu Boahen, Ruthendo Nkomo, Benjamin Tsofa, Kayla F. Laserson, Patricia Njuguna, Pauline Akoo, Joseph Chintedza, Grace Mwangoka, Miguel A. Lanaspa, Robert T. Guiguemdé, Erik Jongert, Allan Jumbe, Larko Owusu, Thor G. Theander, Alma Sykes, Francis Martinson, Edwin Liheluka, Eusebio Macete, Kingsley Osei-Kwakye, Marc Lievens, Saumu Ahmed, Nahya Salim, Otsyula Nekoye, Arlindo Nhamuave, Kafuruki Shubis, Kevin Marsh, Ally Olotu, Trudie Lang, Harry Owusu Boateng, Anangisye Malabeja, Arnaud Flamen, Simon Kariuki, Solange Soulanoudjingar, Jesse Gitaka, Vincent Muturi-Kioi, Daniel Chandramohan
Publikováno v:
New England Journal of Medicine. 365:1863-1875
BACKGROUND An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries. METHODS From March 2009 through January 2011, we enrolled 15,460 children in two ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c16dced5eb2fd8989f7492b258232d8
https://doi.org/10.1056/nejmoa1102287
https://doi.org/10.1056/nejmoa1102287
Autor:
Esther Oguk, Trudie Lang, Harry Owusu Boateng, Laurence Slutsker, Patricia Njuguna, Francis Martinson, Justice Sylverken, Saumu Ahmed, Nahya Salim, Christine Kerubo, Omari Abdul, Pedro Aide, Gerald Tegha, Innocent Valea, Kevin Marsh, Chimwemwe Chawinga, Preeti Vansadia, Ayola A. Adegnika, Ali Hamad, Irving F. Hoffman, Vincent Muturi-Kioi, Evans Kwara, Norbert Awino, Daniel Ansong, Halidou Tinto, Helder Bulo, Seth Owusu-Agyei, Chris Drakeley, Peter G. Kremsner, Stacey M. O. Gondi, Eusebio Macete, Edwin Liheluka, George Odongo, Owusu Boahen, Kwaku Poku Asante, Portia Kamthunzi, Sonia Machevo, Didier Leboulleux, Mary J. Hamel, Selidji T Agnandji, Samwel Gesase, Jane Kilembe, Hermann Sorgho, Lucas Otieno, Kayla F. Laserson, Marc Lievens, Rutendo Nkomo, Robert T. Guiguemdé, Betuel Sigaúque, Biebo Bihoun, Anangisye Malabeja, Jahit Sacarlal, David C. Kaslow, Daniel Chandramohan, David Schellenberg, Olivier Sombié, Bernhards Ogutu, Roma Chilengi, Ali Ali, Maxmillian Mpina, Amanda J. Leach, Thor G. Theander, John Lusingu, Jean-Bosco Ouédraogo, Anita Lumeka Kabwende, Anima Sarfo, David Dosoo, Benjamin Mordmüller, Pedro L. Alonso, Tisungane Mvalo, Ali Mtoro, Charity Maingi, Yolanda Guerra, John Bawa, Alex Agyekum, Mercy Tsidya, Christian Loucq, Simon Kariuki, Meredith McMorrow, Brian Greenwood, Berenger Kaboré, Barbara Gaelle Nfono Ondo Methogo, Didier Lapierre, Joe Cohen, Samuel Adjei, Johan Vekemans, Barbara Savarese, Marla Sillman, Gabriel Mwambingu, David Sambian, Afiya Radford, George Adjei, Philip Bejon, Walter Otieno, Saadou Issifou, Paul Mutani, Umberto D'Alessandro, Chris Odero, Allan Otieno, Béatrice Peggy Abossolo, Tsiri Agbenyega, Marcel Tanner, Ally Olotu, Lincoln Malle, Kingsley Osei-Kwakye, Tapiwa Tembo, Rose Minja, Salim Abdulla, W. Ripley Ballou, Bertrand Lell, Opokua Ofori-Anyinam, Terrell Carter, José Francisco Fernandes, Miguel Lanaspa, Coline Mahende, Theresa Rettig, Aurélie Olivier, Issa Guiraud, Jon Ben Woods, Nekoye Otsyula, Pauline Akoo, Erik Jongert, M.M. Lemnge, Victorine Owira, Kephas Otieno, Sozinho Acácio, John J. Aponte, Martina Oneko, Isaac Asante
BACKGROUND: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beaf1d9dda3fe0877c22029a20ff4a88
